W2O hires eight leaders

Julie Adrian has joined W2O as global chief experience officer, John Capodanno was named president of financial, corporate and capital market communications, Nikki Levy has joined as practice leader for advocacy relations, David Magrini was appointed president of CRM and marketing solutions, Jane Petrino was named practice leader for communications strategy, Marlena Edwards was named head of people and performance, Carrie Galli has joined as head of organizational growth and planning and Jonathan Robbins was named head of talent acquisition.

AbelsonTaylor names VP, engagement strategy

Erica Rivera has been promoted to VP of engagement strategy at AbelsonTaylor. She was previously a senior director and has been with the agency since 2015.

Experity names patient engagement lead

Tim Dybvig has joined healthcare IT provider Experity as SVP of patient engagement. Dybvig is joining Experity after its recent acquisition of his previous company, Calibrater Health, which he cofounded and served as CEO.

Avant Healthcare appoints CEO

Arun Divakaruni has been promoted to chief executive officer at medical education agency Avant Healthcare. He previously served as chief science officer and joined the company in 2019.

Rain Therapeutics names scientific chief

Robert Doebele has been named EVP and chief scientific officer at Rain Therapeutics. Previously, Doebele served as a scientific advisor on Rain’s board and will transition to this full time role. He was also previously an associate professor of medicine at University of Colorado, Denver.

Biofidelity appoints commercial chief

Stephen Miller has been appointed chief commercial officer at Biofidelity, a cancer diagnostics company. 

Aprecia names regulatory SVP

Kathi Rinesmith has been named SVP of regulatory affairs at Aprecia. Previously, she was director of global regulatory affairs and global pharmacovigilance at Adare Pharmaceuticals.

Tizona Therapeutics names CEO

Christine O’Brien has been promoted to chief executive officer of Tizona. O’Brien previously held the position of chief operating officer at the company.

miRagen makes leadership changes

William Marshall has stepped down as CEO of miRagen Therapeutics. The company has appointed Lee Rauch, the company’s current chief operating officer, as president and CEO.

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at carrie.gavit@haymarketmedia.com.